Literature DB >> 6606352

Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography.

J S Rellas, J R Corbett, P Kulkarni, C Morgan, M D Devous, L M Buja, L Bush, R W Parkey, J T Willerson, S E Lewis.   

Abstract

The ability of an iodinated fatty acid, iodine-123 phenylpentadecanoic acid (1-123 PPA), and single-photon emission computed tomography (SPECT) to detect myocardium injured by temporary or permanent coronary arterial occlusion was evaluated. In 5 control dogs, 11 dogs that underwent 90 to 120 minutes of fixed left anterior descending coronary artery (LAD) occlusion, and 8 dogs that underwent 90 minutes of temporary LAD occlusion and up to 90 minutes of reflow, 2 to 6 mCi of I-123 PPA were injected and the dogs were imaged with SPECT. Control dogs showed relatively uniform uptake and clearance of I-123 PPA in similar left ventricular (LV) regions. Dogs with permanent LAD occlusion were identified by computer algorithm as having regions of decreased I-123 PPA uptake in the infarct-related area and a reduced rate of I-123 PPA clearance (-9.4% in infarct sectors [washin], +3.7% in sectors adjacent to the area of infarction, and +15.4% in control LV sectors [p less than 0.01]). Dogs with temporary LAD occlusion and reperfusion had decreased clearance of I-123 PPA from the regions with infarction; I-123 PPA clearance was -5.2 +/- 16.4% in infarct sectors, 12.7 +/- 7.4% in periinfarct zones, and 30.4 +/- 12% in control LV regions. These data demonstrate that tomographic analysis of I-123 PPA uptake and clearance permits the relatively noninvasive detection of LV myocardium injured by permanent or temporary LAD occlusion and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606352     DOI: 10.1016/0002-9149(83)90596-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Does myocardial free fatty acid metabolism predict subsequent mechanical dysfunction associated with cardiomyopathy?

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

2.  Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure.

Authors:  G L Freeman; J T Colston; D D Miller
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 3.  Experimental and clinical experience with iodine 123-labeled iodophenylpentadecanoic acid in cardiology.

Authors:  S N Reske
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 4.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

5.  Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.

Authors:  J Taki; K Nakajima; I Matsunari; H Bunko; S Takada; N Tonami
Journal:  Eur J Nucl Med       Date:  1995-12

6.  Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.

Authors:  Y Takeishi; J Chiba; S Abe; I Tonooka; A Komatani; H Tomoike
Journal:  Eur J Nucl Med       Date:  1992

7.  Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.

Authors:  Y Yazaki; M Isobe; W Takahashi; H Kitabayashi; O Nishiyama; M Sekiguchi; T Takemura
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

8.  Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo.

Authors:  M Huettinger; J R Corbett; W J Schneider; J T Willerson; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.